Epigenetic therapy of hematological malignancies: where are we now? is a research paper published in Therapeutic Advances in Hematology (2013). On theSindex it has a DataRank of 1.3. It has been cited 25 times, with 25 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Base Score Contribution
0.489
From this paper's citation signal
Citation Network Contribution
0.769
From 23 citing papers with measurable signal
Ranked by each citer's contribution to N(p) β log1p(Cq) divided by its reference count β out of 25 citers.
NCI NIH HHS
Grant: P30 CA060553
NCI NIH HHS
Grant: R01 CA123204
NCI NIH HHS
Grant: U54 CA143869
NCI NIH HHS
Grant: T32 CA070085
FWCI
0.98
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals